Sarepta Therapeutics, Inc. (SRPT)
USD 51.38
(-5.6%)
USD 51.38
(-5.6%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -535.97 Million USD | 23.81% |
| 2022 | -703.48 Million USD | -67.99% |
| 2021 | -418.78 Million USD | 24.43% |
| 2020 | -554.12 Million USD | 22.51% |
| 2019 | -715.07 Million USD | -97.58% |
| 2018 | -361.91 Million USD | -614.01% |
| 2017 | -50.68 Million USD | 81.03% |
| 2016 | -267.26 Million USD | -21.47% |
| 2015 | -220.03 Million USD | -62.04% |
| 2014 | -135.78 Million USD | -21.26% |
| 2013 | -111.98 Million USD | 7.67% |
| 2012 | -121.28 Million USD | -5132.4% |
| 2011 | -2.31 Million USD | 92.8% |
| 2010 | -32.17 Million USD | -27.89% |
| 2009 | -25.15 Million USD | -5.04% |
| 2008 | -23.95 Million USD | 11.83% |
| 2007 | -27.16 Million USD | 12.57% |
| 2006 | -31.07 Million USD | -86.34% |
| 2005 | -16.67 Million USD | 32.7% |
| 2004 | -24.77 Million USD | -69.52% |
| 2003 | -14.61 Million USD | 50.21% |
| 2002 | -29.35 Million USD | -9.04% |
| 2001 | -26.92 Million USD | -191.4% |
| 2000 | -9.23 Million USD | -11.32% |
| 1999 | -8.3 Million USD | 68.91% |
| 1998 | -26.7 Million USD | -641.67% |
| 1997 | -3.6 Million USD | -71.43% |
| 1996 | -2.1 Million USD | 19.23% |
| 1995 | -2.6 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 36.11 Million USD | -20.89% |
| 2024 Q2 | 6.46 Million USD | -82.11% |
| 2023 Q2 | -23.94 Million USD | 95.37% |
| 2023 FY | -535.97 Million USD | 23.81% |
| 2023 Q4 | 45.65 Million USD | 211.53% |
| 2023 Q1 | -516.75 Million USD | -373.03% |
| 2023 Q3 | -40.93 Million USD | -71.0% |
| 2022 FY | -703.48 Million USD | -67.99% |
| 2022 Q4 | -109.24 Million USD | 57.61% |
| 2022 Q3 | -257.73 Million USD | -11.34% |
| 2022 Q1 | -105.02 Million USD | 13.9% |
| 2022 Q2 | -231.48 Million USD | -120.41% |
| 2021 FY | -418.78 Million USD | 24.43% |
| 2021 Q1 | -167.25 Million USD | 11.66% |
| 2021 Q2 | -81.4 Million USD | 51.33% |
| 2021 Q3 | -48.14 Million USD | 40.86% |
| 2021 Q4 | -121.98 Million USD | -153.37% |
| 2020 Q3 | -196.49 Million USD | -30.29% |
| 2020 Q2 | -150.82 Million USD | -762.22% |
| 2020 FY | -554.12 Million USD | 22.51% |
| 2020 Q1 | -17.49 Million USD | 92.58% |
| 2020 Q4 | -189.31 Million USD | 3.65% |
| 2019 Q4 | -235.7 Million USD | -86.58% |
| 2019 Q2 | -276.4 Million USD | -260.64% |
| 2019 Q3 | -126.32 Million USD | 54.3% |
| 2019 Q1 | -76.64 Million USD | 45.6% |
| 2019 FY | -715.07 Million USD | -97.58% |
| 2018 Q2 | -109.26 Million USD | -208.99% |
| 2018 FY | -361.91 Million USD | -614.01% |
| 2018 Q4 | -140.89 Million USD | -84.43% |
| 2018 Q3 | -76.39 Million USD | 30.09% |
| 2018 Q1 | -35.36 Million USD | -47.36% |
| 2017 Q4 | -23.99 Million USD | 49.73% |
| 2017 FY | -50.68 Million USD | 81.03% |
| 2017 Q1 | 84.09 Million USD | 195.07% |
| 2017 Q2 | -63.04 Million USD | -174.97% |
| 2017 Q3 | -47.73 Million USD | 24.29% |
| 2016 Q3 | -56.74 Million USD | 8.92% |
| 2016 FY | -267.26 Million USD | -21.47% |
| 2016 Q1 | -59.77 Million USD | 7.59% |
| 2016 Q4 | -88.45 Million USD | -55.88% |
| 2016 Q2 | -62.3 Million USD | -4.23% |
| 2015 Q3 | -51.93 Million USD | -24.1% |
| 2015 FY | -220.03 Million USD | -62.04% |
| 2015 Q1 | -61.55 Million USD | -38.6% |
| 2015 Q2 | -41.85 Million USD | 32.01% |
| 2015 Q4 | -64.68 Million USD | -24.53% |
| 2014 FY | -135.78 Million USD | -21.26% |
| 2014 Q2 | -33.87 Million USD | -19.81% |
| 2014 Q1 | -28.27 Million USD | -220.56% |
| 2014 Q3 | -29.22 Million USD | 13.72% |
| 2014 Q4 | -44.41 Million USD | -51.97% |
| 2013 Q2 | -19.05 Million USD | 54.73% |
| 2013 Q1 | -42.08 Million USD | 32.2% |
| 2013 Q3 | -42.03 Million USD | -120.62% |
| 2013 Q4 | -8.82 Million USD | 79.01% |
| 2013 FY | -111.98 Million USD | 7.67% |
| 2012 Q3 | -49.55 Million USD | -716.5% |
| 2012 FY | -121.28 Million USD | -5132.4% |
| 2012 Q2 | 8.03 Million USD | 145.4% |
| 2012 Q1 | -17.7 Million USD | -1155.6% |
| 2012 Q4 | -62.06 Million USD | -25.25% |
| 2011 Q2 | 1.27 Million USD | -30.22% |
| 2011 FY | -2.31 Million USD | 92.8% |
| 2011 Q3 | -4.02 Million USD | -414.31% |
| 2011 Q4 | -1.41 Million USD | 64.93% |
| 2011 Q1 | 1.83 Million USD | 123.98% |
| 2010 Q3 | -7.29 Million USD | 56.21% |
| 2010 Q2 | -16.65 Million USD | -2752.05% |
| 2010 Q1 | -584 Thousand USD | -116.57% |
| 2010 Q4 | -7.64 Million USD | -4.81% |
| 2010 FY | -32.17 Million USD | -27.89% |
| 2009 Q3 | -8.09 Million USD | 58.87% |
| 2009 FY | -25.15 Million USD | -5.04% |
| 2009 Q1 | -927 Thousand USD | 18.72% |
| 2009 Q2 | -19.66 Million USD | -2021.68% |
| 2009 Q4 | 3.52 Million USD | 143.57% |
| 2008 Q4 | -1.14 Million USD | 81.14% |
| 2008 FY | -23.95 Million USD | 11.83% |
| 2008 Q2 | -1.75 Million USD | 88.34% |
| 2008 Q1 | -15.01 Million USD | -263.79% |
| 2008 Q3 | -6.04 Million USD | -245.42% |
| 2007 Q3 | -7.03 Million USD | 17.59% |
| 2007 Q1 | -9.72 Million USD | -16.73% |
| 2007 FY | -27.16 Million USD | 12.57% |
| 2007 Q4 | -4.12 Million USD | 41.33% |
| 2007 Q2 | -8.53 Million USD | 12.2% |
| 2006 Q3 | -6.78 Million USD | 1.76% |
| 2006 Q2 | -6.9 Million USD | 23.83% |
| 2006 Q1 | -9.06 Million USD | -99.08% |
| 2006 FY | -31.07 Million USD | -86.34% |
| 2006 Q4 | -8.32 Million USD | -22.84% |
| 2005 Q1 | -5.49 Million USD | -10.2% |
| 2005 Q4 | -4.55 Million USD | -168.93% |
| 2005 Q3 | -1.69 Million USD | 65.69% |
| 2005 Q2 | -4.93 Million USD | 10.3% |
| 2005 FY | -16.67 Million USD | 32.7% |
| 2004 Q1 | -7.53 Million USD | -143.28% |
| 2004 Q3 | -5.1 Million USD | 28.55% |
| 2004 Q4 | -4.99 Million USD | 2.29% |
| 2004 Q2 | -7.14 Million USD | 5.11% |
| 2004 FY | -24.77 Million USD | -69.52% |
| 2003 Q3 | -4.6 Million USD | -31.61% |
| 2003 Q2 | -3.49 Million USD | -2.31% |
| 2003 Q1 | -3.41 Million USD | 14.4% |
| 2003 FY | -14.61 Million USD | 50.21% |
| 2003 Q4 | -3.09 Million USD | 32.74% |
| 2002 Q4 | -3.99 Million USD | 43.36% |
| 2002 Q1 | -7.81 Million USD | -69.76% |
| 2002 Q2 | -10.49 Million USD | -34.31% |
| 2002 Q3 | -7.05 Million USD | 32.83% |
| 2002 FY | -29.35 Million USD | -9.04% |
| 2001 Q3 | -15.59 Million USD | -339.82% |
| 2001 Q1 | -3.17 Million USD | -5.69% |
| 2001 Q2 | -3.54 Million USD | -11.56% |
| 2001 Q4 | -4.6 Million USD | 70.48% |
| 2001 FY | -26.92 Million USD | -191.4% |
| 2000 FY | -9.23 Million USD | -11.32% |
| 2000 Q2 | -2.84 Million USD | -149.18% |
| 2000 Q1 | -1.13 Million USD | 52.5% |
| 2000 Q3 | -2.25 Million USD | 20.71% |
| 2000 Q4 | -3 Million USD | -33.54% |
| 1999 Q4 | -2.4 Million USD | -9.09% |
| 1999 FY | -8.3 Million USD | 68.91% |
| 1999 Q1 | -1.7 Million USD | 29.17% |
| 1999 Q3 | -2.2 Million USD | -10.0% |
| 1999 Q2 | -2 Million USD | -17.65% |
| 1998 Q2 | -1.7 Million USD | -21.43% |
| 1998 Q3 | -21.3 Million USD | -1152.94% |
| 1998 FY | -26.7 Million USD | -641.67% |
| 1998 Q4 | -2.4 Million USD | 88.73% |
| 1998 Q1 | -1.4 Million USD | -75.0% |
| 1997 Q1 | -300 Thousand USD | 55.22% |
| 1997 Q3 | -900 Thousand USD | 30.77% |
| 1997 FY | -3.6 Million USD | -71.43% |
| 1997 Q4 | -800 Thousand USD | 11.11% |
| 1997 Q2 | -1.3 Million USD | -333.33% |
| 1996 Q3 | -580 Thousand USD | 0.0% |
| 1996 FY | -2.1 Million USD | 19.23% |
| 1996 Q1 | -250 Thousand USD | 0.0% |
| 1996 Q4 | -670 Thousand USD | -15.52% |
| 1996 Q2 | -580 Thousand USD | -132.0% |
| 1995 FY | -2.6 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -266.11% |
| Alkermes plc | 355.75 Million USD | 250.658% |
| Agenus Inc. | -245.76 Million USD | -118.089% |
| Aptorum Group Limited | -2.82 Million USD | -18875.008% |
| Ardelyx, Inc. | -66.06 Million USD | -711.263% |
| Dyadic International, Inc. | -6.79 Million USD | -7787.279% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -57162.5% |
| Lantern Pharma Inc. | -15.96 Million USD | -3257.929% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -2716.65% |
| Novavax, Inc. | -545.06 Million USD | 1.667% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -819.453% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -626.355% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -2789.972% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -5267.284% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -808.703% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | -43.451% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2102.106% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -1335.396% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -225.675% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -630.742% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -2541.452% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -760.938% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -1549.922% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -304.532% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | -21.746% |
| AlloVir, Inc. | -190.41 Million USD | -181.474% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -161.102% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -1783.794% |
| Bicycle Therapeutics plc | -180.66 Million USD | -196.671% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -199.34% |
| ChromaDex Corporation | -4.93 Million USD | -10754.131% |
| Chimerix, Inc. | -82.09 Million USD | -552.874% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -1101.653% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -425.107% |
| CRISPR Therapeutics AG | -153.61 Million USD | -248.921% |
| Precision BioSciences, Inc. | -61.31 Million USD | -774.08% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -233.054% |
| Fortress Biotech, Inc. | -60.63 Million USD | -783.911% |
| Fortress Biotech, Inc. | -60.63 Million USD | -783.911% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -556.996% |
| ImmuCell Corporation | -5.77 Million USD | -9181.633% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -374.48% |
| Immix Biopharma, Inc. | -15.42 Million USD | -3374.493% |
| Incyte Corporation | 597.59 Million USD | 189.688% |
| Innoviva, Inc. | 179.72 Million USD | 398.226% |
| IO Biotech, Inc. | -86.08 Million USD | -522.628% |
| Jaguar Health, Inc. | -41.3 Million USD | -1197.765% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -250.33% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 1127.681% |
| ContextLogic Inc. | -317 Million USD | -69.078% |
| MiMedx Group, Inc. | 67.43 Million USD | 894.758% |
| MEI Pharma, Inc. | 17.77 Million USD | 3114.833% |
| NextCure, Inc. | -62.72 Million USD | -754.514% |
| Onconetix, Inc. | -37.4 Million USD | -1332.722% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -1257.626% |
| Opthea Limited | -220.24 Million USD | -143.358% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -947.668% |
| Vaxcyte, Inc. | -402.26 Million USD | -33.239% |
| PDS Biotechnology Corporation | -42.94 Million USD | -1148.136% |
| Precigen, Inc. | -95.9 Million USD | -458.868% |
| Pharming Group N.V. | -10.54 Million USD | -4981.314% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -165.872% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -2083.828% |
| PureTech Health plc | -65.69 Million USD | -715.832% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -2036.132% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -152.557% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -2102.106% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | -107.879% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -1867.755% |
| Acelyrin, Inc. | -381.64 Million USD | -40.44% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -4273122.092% |
| Summit Therapeutics Inc. | -614.92 Million USD | 12.839% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -1471.734% |
| Senti Biosciences, Inc. | -92.91 Million USD | -476.822% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -411.922% |
| Elevation Oncology, Inc. | -45.7 Million USD | -1072.714% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -1425.262% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -4000.234% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -7917.607% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -1725.41% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6204.87% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -831.923% |
| Seer, Inc. | -86.27 Million USD | -521.228% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -700.025% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -714.988% |
| ESSA Pharma Inc. | -26.58 Million USD | -1916.29% |
| GlycoMimetics, Inc. | -36.89 Million USD | -1352.535% |
| GT Biopharma, Inc. | -7.59 Million USD | -6955.114% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | -122.064% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -932.214% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 850.563% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -884.854% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -991.158% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -5287.924% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 6.436% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -14838.043% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -949.741% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | -118.236% |
| Aptose Biosciences Inc. | -51.2 Million USD | -946.687% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -445.258% |
| Soligenix, Inc. | -6.14 Million USD | -8628.229% |
| Century Therapeutics, Inc. | -136.67 Million USD | -292.16% |
| Kura Oncology, Inc. | -152.63 Million USD | -251.159% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -500.75% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -4986.136% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 94884.339% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -94096.309% |
| Autolus Therapeutics plc | -208.38 Million USD | -157.208% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -645.469% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -657.083% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -2373.588% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -137.948% |
| GRI Bio, Inc. | -13.03 Million USD | -4011.199% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -12863.282% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -331.947% |
| IGM Biosciences, Inc. | -246.41 Million USD | -117.509% |
| INmune Bio, Inc. | -30 Million USD | -1686.114% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -384.788% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1170.275% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3257.903% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -3293.337% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -798.01% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -429.794% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | -94.106% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -125.303% |
| Verastem, Inc. | -87.36 Million USD | -513.478% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -889.106% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -232.212% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -359.443% |
| Histogen Inc. | -10.62 Million USD | -4946.389% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -3651.565% |
| Surrozen, Inc. | -43.04 Million USD | -1145.242% |
| Organovo Holdings, Inc. | -14.67 Million USD | -3553.309% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10436.15% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -924.05% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -2021.589% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -1889.669% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -6313.444% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -254.752% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -995.484% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -1703.119% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -5044.867% |
| Apollomics, Inc. | -172.6 Million USD | -210.529% |
| Amarin Corporation plc | -59.11 Million USD | -806.714% |
| Mesoblast Limited | -87.95 Million USD | -509.369% |
| Turnstone Biologics Corp. | -55.2 Million USD | -870.973% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -264.704% |
| Synaptogenix, Inc. | -6.03 Million USD | -8775.99% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -3206.867% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -586.974% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11086.075% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -6279.011% |
| Exelixis, Inc. | 207.76 Million USD | 357.973% |
| Better Therapeutics, Inc. | -39.76 Million USD | -1248.031% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -272.341% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | -1.39% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4303.35% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -6776.181% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -1643.071% |
| Gritstone bio, Inc. | -138.49 Million USD | -287.015% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -731.423% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -13299.592% |
| Avid Bioservices, Inc. | -140.75 Million USD | -280.793% |
| Insmed Incorporated | -749.56 Million USD | 28.495% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -3428.6% |
| MediWound Ltd. | -6.71 Million USD | -7880.599% |
| OmniAb, Inc. | -50.61 Million USD | -958.845% |
| Alector, Inc. | -130.39 Million USD | -311.054% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -371.296% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -933.767% |
| Zai Lab Limited | -334.62 Million USD | -60.175% |
| Revance Therapeutics, Inc. | -323.98 Million USD | -65.432% |
| Aura Biosciences, Inc. | -76.4 Million USD | -601.467% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -128.433% |
| Immunic, Inc. | -93.61 Million USD | -472.552% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -294.411% |
| Veracyte, Inc. | -74.4 Million USD | -620.36% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -6882.913% |
| FibroGen, Inc. | -284.23 Million USD | -88.57% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1943.218% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7554.748% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -2745.992% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 229.203% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -2276.311% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 1187.814% |
| TG Therapeutics, Inc. | 12.67 Million USD | 4329.616% |
| Galecto, Inc. | -38.34 Million USD | -1297.63% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -2740.968% |
| Fortrea Holdings Inc. | -3.4 Million USD | -15664.029% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -323.215% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -2978.381% |
| XBiotech Inc. | -24.55 Million USD | -2082.583% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -731.423% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -755.101% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -444.548% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -2401.409% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -871.096% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 11.648% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -685.257% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -941300.569% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -136.594% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -2306.99% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -143.947% |
| NexImmune, Inc. | -32.34 Million USD | -1557.094% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -10038.456% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -3715.898% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 113.557% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -2112.861% |
| Scopus BioPharma Inc. | -11.6 Million USD | -4516.58% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -358.892% |
| Ainos, Inc. | -13.77 Million USD | -3792.198% |
| Pluri Inc. | -20.88 Million USD | -2465.957% |
| Prothena Corporation plc | -147.02 Million USD | -264.541% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -370.688% |
| Celularity Inc. | -196.29 Million USD | -173.047% |
| Rallybio Corporation | -74.56 Million USD | -618.815% |
| Cue Biopharma, Inc. | -50.73 Million USD | -956.466% |
| MeiraGTx Holdings plc | -84.02 Million USD | -537.863% |
| Omeros Corporation | -117.81 Million USD | -354.939% |
| Humacyte, Inc. | -110.77 Million USD | -383.839% |
| Immunocore Holdings plc | -55.28 Million USD | -869.445% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -2880.299% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -2237.347% |
| Blueprint Medicines Corporation | -506.98 Million USD | -5.719% |
| CalciMedica, Inc. | -34.35 Million USD | -1460.023% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -691.987% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -279.037% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -223.289% |
| Sana Biotechnology, Inc. | -283.25 Million USD | -89.221% |
| Pulmatrix, Inc. | -14.12 Million USD | -3695.602% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -1422.878% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -548.584% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | -11.385% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -411.082% |
| Cytokinetics, Incorporated | -526.24 Million USD | -1.85% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -1386.142% |
| Nutriband Inc. | -5.48 Million USD | -9671.127% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -1226.019% |
| Vor Biopharma Inc. | -117.86 Million USD | -354.746% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 112.324% |
| Evogene Ltd. | -23.87 Million USD | -2144.554% |
| ProKidney Corp. | -35.46 Million USD | -1411.157% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -347.531% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -6731.745% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 16.671% |
| CorMedix Inc. | -46.33 Million USD | -1056.638% |
| BioLineRx Ltd. | -60.61 Million USD | -784.246% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -426.79% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -1205.16% |
| Atai Life Sciences N.V. | -40.22 Million USD | -1232.481% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -564.57% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -609.706% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | -83.434% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -1822.718% |
| MediciNova, Inc. | -8.57 Million USD | -6153.001% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -334.775% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6298.324% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1964.089% |
| Axsome Therapeutics, Inc. | -239.23 Million USD | -124.035% |
| Biomea Fusion, Inc. | -117.25 Million USD | -357.104% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 14.463% |
| Mereo BioPharma Group plc | -29.46 Million USD | -1718.968% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -249.941% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -156.007% |
| Absci Corporation | -110.56 Million USD | -384.758% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1677.701% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -431.528% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -127.17% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 3905.574% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -177.763% |
| Allakos Inc. | -185.7 Million USD | -188.624% |
| Imunon, Inc. | -19.51 Million USD | -2646.491% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -450.652% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 604.972% |
| BioAtla, Inc. | -123.46 Million USD | -334.123% |
| NLS Pharmaceutics AG | -12.17 Million USD | -4303.35% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -3233.605% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | -63.775% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -1350.586% |
| XOMA Corporation | -40.83 Million USD | -1212.672% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -426.138% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -352.252% |
| aTyr Pharma, Inc. | -50.38 Million USD | -963.679% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -511.295% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -253.176% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -125.452% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -1426.174% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -6523.591% |
| Akari Therapeutics, Plc | -10 Million USD | -5255.486% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -796003.973% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 290.337% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7941.787% |
| UroGen Pharma Ltd. | -102.24 Million USD | -424.214% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -401.884% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -6791.659% |
| Orgenesis Inc. | -55.36 Million USD | -868.149% |
| Entera Bio Ltd. | -8.88 Million USD | -5929.666% |
| GH Research PLC | -35.58 Million USD | -1406.103% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -2471.867% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -592.584% |
| Xencor, Inc. | -126.08 Million USD | -325.085% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -14133.123% |
| Replimune Group, Inc. | -215.79 Million USD | -148.374% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -2420.283% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 21462.176% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -7941.787% |
| Portage Biotech Inc. | -75.33 Million USD | -611.42% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -6298.324% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -454.526% |
| OncoCyte Corporation | -27.78 Million USD | -1829.293% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -3894.697% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -4719.278% |
| Purple Biotech Ltd. | -19.88 Million USD | -2596.061% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -7536.088% |
| scPharmaceuticals Inc. | -54.81 Million USD | -877.882% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -2961.651% |
| HilleVax, Inc. | -123.56 Million USD | -333.758% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -5203.028% |
| Tharimmune, Inc. | -9.31 Million USD | -5651.385% |
| Genprex, Inc. | -30.86 Million USD | -1636.776% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -127.181% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -1681.01% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -29977.273% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -10020.383% |
| OKYO Pharma Limited | -16.82 Thousand USD | -3185411.719% |
| Savara Inc. | -54.69 Million USD | -879.884% |
| Curis, Inc. | -47.41 Million USD | -1030.443% |
| Daré Bioscience, Inc. | -30.16 Million USD | -1677.03% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -3370.21% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -9524.295% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -1697.676% |
| BeiGene, Ltd. | -881.7 Million USD | 39.212% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -2417.033% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | -22.827% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -578.839% |
| Erasca, Inc. | -125.04 Million USD | -328.638% |
| bluebird bio, Inc. | -211.91 Million USD | -152.923% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10618.475% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 419.71% |
| DBV Technologies S.A. | -72.72 Million USD | -636.981% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -10618.475% |
| Moderna, Inc. | -4.71 Billion USD | 88.63% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -1234.704% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -9313.014% |
| Molecular Templates, Inc. | -8.12 Million USD | -6497.452% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -787.555% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -381.133% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -295.987% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -1018.506% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -278.972% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -178.56% |
| MacroGenics, Inc. | -9.05 Million USD | -5817.167% |
| RenovoRx, Inc. | -10.23 Million USD | -5138.243% |
| Adicet Bio, Inc. | -142.65 Million USD | -275.708% |
| Prime Medicine, Inc. | -198.13 Million USD | -170.514% |
| Aditxt, Inc. | -32.38 Million USD | -1555.229% |
| Adagene Inc. | -18.94 Million USD | -2728.917% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7230.379% |
| Quantum-Si incorporated | -95.96 Million USD | -458.542% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -350.291% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3576.674% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 505.031% |
| SciSparc Ltd. | -5.12 Million USD | -10364.213% |
| Vericel Corporation | -3.18 Million USD | -16744.029% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -445604.093% |
| Minerva Neurosciences, Inc. | -30 Million USD | -1686.271% |
| Generation Bio Co. | -126.61 Million USD | -323.322% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -635.313% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -550.126% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | -104.462% |
| Invivyd, Inc. | -198.64 Million USD | -169.819% |
| Relay Therapeutics, Inc. | -341.97 Million USD | -56.731% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -6070.178% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 2450.158% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -5328.165% |
| 2seventy bio, Inc. | -217.57 Million USD | -146.347% |
| ADMA Biologics, Inc. | -28.23 Million USD | -1798.003% |
| Clene Inc. | -49.5 Million USD | -982.694% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -2304.828% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -984.227% |
| GeoVax Labs, Inc. | -25.96 Million USD | -1964.089% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | -63.375% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -1546.985% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 2459.054% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -442.532% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -616.988% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -233.309% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 12.858% |
| Evaxion Biotech A/S | -22.12 Million USD | -2322.495% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -563.864% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -167.897% |
| Trevena, Inc. | -40.28 Million USD | -1230.331% |
| Surrozen, Inc. | -43.04 Million USD | -1145.242% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -675.273% |
| Cingulate Inc. | -23.53 Million USD | -2177.367% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -7654.297% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -1244.649% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -6851.105% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -494.144% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -774.55% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -800.756% |
| Clearmind Medicine Inc. | -11.95 Million USD | -4383.276% |
| Kronos Bio, Inc. | -112.67 Million USD | -375.692% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -674.567% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -21132723.127% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -523.991% |
| Statera Biopharma, Inc. | -174.4 Million USD | -207.312% |
| ImmunityBio, Inc. | -583.19 Million USD | 8.097% |
| Korro Bio, Inc. | -81.17 Million USD | -560.298% |
| Kineta, Inc. | -14.09 Million USD | -3701.525% |
| BioVie Inc. | -32.12 Million USD | -1568.643% |
| Codexis, Inc. | -76.24 Million USD | -603.013% |
| Celularity Inc. | -196.29 Million USD | -173.047% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -149.839% |
| Celcuity Inc. | -63.77 Million USD | -740.364% |
| Virax Biolabs Group Limited | -6.73 Million USD | -7859.814% |
| Cibus, Inc. | -267.62 Million USD | -100.27% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -1229.11% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -1396.683% |
| IN8bio, Inc. | -30 Million USD | -1686.173% |
| Kodiak Sciences Inc. | -260.49 Million USD | -105.756% |
| Annexon, Inc. | -134.23 Million USD | -299.277% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -357.455% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -775.379% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -1599.141% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | -46.327% |
| Eyenovia, Inc. | -27.26 Million USD | -1866.087% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 2582.409% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -100082.617% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -601.504% |
| Arcellx, Inc. | -70.69 Million USD | -658.208% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -1193.35% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -300.533% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -1684.389% |
| Moolec Science SA | -51.78 Million USD | -934.927% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -923.423% |
| Geron Corporation | -184.12 Million USD | -191.091% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -1176.926% |
| Royalty Pharma plc | 1.13 Billion USD | 147.23% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -294.228% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -5927.765% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -2423.048% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -212.214% |
| Humacyte, Inc. | -110.77 Million USD | -383.839% |
| Structure Therapeutics Inc. | -89.62 Million USD | -498.055% |
| 89bio, Inc. | -142.18 Million USD | -276.947% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -677.229% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -5065.048% |
| Genelux Corporation | -28.29 Million USD | -1794.112% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -1744.063% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -202.608% |
| Notable Labs, Ltd. | -11.26 Million USD | -4658.319% |
| Liquidia Corporation | -78.5 Million USD | -582.756% |
| Mustang Bio, Inc. | -51.6 Million USD | -938.675% |
| Immunovant, Inc. | -259.33 Million USD | -106.673% |
| Quantum-Si incorporated | -95.96 Million USD | -458.542% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -635.737% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -2665.476% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -458.368% |
| Acasti Pharma Inc. | -12.85 Million USD | -4070.054% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -2286.59% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -3257.903% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -193.858% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -12360.186% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -4198.132% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -1717.426% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -1274.723% |
| PepGen Inc. | -78.62 Million USD | -581.679% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -1700.453% |
| United Therapeutics Corporation | 984.8 Million USD | 154.425% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -2307.803% |
| Solid Biosciences Inc. | -96.01 Million USD | -458.222% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11086.075% |
| Immuneering Corporation | -53.47 Million USD | -902.358% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -10436.15% |
| Silo Pharma, Inc. | -3.7 Million USD | -14383.191% |
| Belite Bio, Inc | -31.63 Million USD | -1594.414% |
| XOMA Corporation | -40.83 Million USD | -1212.672% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -885.886% |
| Bionomics Limited | -15.49 Billion USD | 96.54% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -538.182% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1738.245% |
| uniQure N.V. | -308.47 Million USD | -73.749% |
| Cassava Sciences, Inc. | -97.21 Million USD | -451.32% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7230.379% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -334.236% |
| Forte Biosciences, Inc. | -31.47 Million USD | -1602.812% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -6434.948% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -1743.873% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -100082.617% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -1943.218% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -3151.301% |
| Altimmune, Inc. | -88.44 Million USD | -505.987% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -253.584% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -1738.245% |
| Compugen Ltd. | -18.75 Million USD | -2757.934% |
| Peak Bio, Inc. | -1259.26 USD | -42562754.375% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -1063.928% |
| Benitec Biopharma Inc. | -21.75 Million USD | -2364.149% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | -58.203% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -546.114% |
| Zura Bio Limited | -60.36 Million USD | -787.967% |
| PolyPid Ltd. | -23.86 Million USD | -2145.871% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -3306.922% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -546.114% |
| Instil Bio, Inc. | -156.08 Million USD | -243.383% |
| argenx SE | -295.05 Million USD | -81.654% |
| Immunome, Inc. | -106.8 Million USD | -401.823% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -1161.3% |
| Verona Pharma plc | -54.36 Million USD | -885.814% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -436.422% |
| Shattuck Labs, Inc. | -87.29 Million USD | -513.963% |
| CervoMed Inc. | -2.17 Million USD | -24578.1% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -329.982% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -3925.06% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -1130.575% |
| Moolec Science SA | -51.78 Million USD | -934.927% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -3099514.671% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -296.675% |
| AnaptysBio, Inc. | -163.61 Million USD | -227.576% |
| Design Therapeutics, Inc. | -66.86 Million USD | -701.617% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -558.335% |
| NeurAxis, Inc. | -14.62 Million USD | -3564.378% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -1314.859% |
| Lumos Pharma, Inc. | -34.03 Million USD | -1474.828% |
| Achilles Therapeutics plc | -69.66 Million USD | -669.363% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -436.422% |
| 180 Life Sciences Corp. | -19.93 Million USD | -2588.608% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 17913.706% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -21132723.127% |
| Nutriband Inc. | -5.48 Million USD | -9671.127% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -432.267% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -1002.675% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -595.252% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -1477.795% |
| MoonLake Immunotherapeutics | -36 Million USD | -1388.525% |
| Palisade Bio, Inc. | -12.3 Million USD | -4257.537% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -1172.379% |
| Beam Therapeutics Inc. | -132.52 Million USD | -304.429% |
| Neurogene Inc. | -36.31 Million USD | -1375.83% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -227.985% |
| AEON Biopharma, Inc. | -52.55 Million USD | -919.821% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -446.096% |
| Sesen Bio, Inc. | -19.88 Million USD | -2595.519% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -648.739% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -4183.055% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | -20.705% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -380.412% |
| Athira Pharma, Inc. | -117.67 Million USD | -355.484% |
| Vaccinex, Inc. | -20.25 Million USD | -2546.669% |
| HCW Biologics Inc. | -24.99 Million USD | -2044.399% |
| XOMA Corporation | -40.83 Million USD | -1212.672% |
| Nektar Therapeutics | -276.05 Million USD | -94.155% |
| Arvinas, Inc. | -367.3 Million USD | -45.923% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -796003.973% |
| Merus N.V. | -154.93 Million USD | -245.928% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -450.126% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -1607.749% |
| Rezolute, Inc. | -68.45 Million USD | -682.917% |
| Clene Inc. | -49.5 Million USD | -982.694% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3375.074% |
| BeyondSpring Inc. | -21.02 Million USD | -2449.115% |
| Synlogic, Inc. | -57.28 Million USD | -835.681% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -4403.63% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -4850.831% |
| Peak Bio, Inc. | -1259.26 USD | -42562754.375% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -1334.321% |
| Krystal Biotech, Inc. | 10.93 Million USD | 5002.827% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -274.55% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | -64.863% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -11503.833% |
| MannKind Corporation | -11.93 Million USD | -4389.672% |
| Ikena Oncology, Inc. | -68.16 Million USD | -686.282% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -2450.45% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -476.735% |
| Gossamer Bio, Inc. | -179.81 Million USD | -198.068% |
| CohBar, Inc. | -11.96 Million USD | -4380.619% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -1978.397% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -1677.701% |
| Legend Biotech Corporation | -518.25 Million USD | -3.42% |
| Mural Oncology plc | -207.44 Million USD | -158.368% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -331.839% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -2830.481% |
| Disc Medicine, Inc. | -76.42 Million USD | -601.274% |
| Champions Oncology, Inc. | -7.27 Million USD | -7266.369% |
| REGENXBIO Inc. | -263.49 Million USD | -103.411% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -4950.158% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -1028.254% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -1311.079% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -435.105% |
| Vaxart, Inc. | -82.46 Million USD | -549.945% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 160686.105% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -1327.654% |
| Cellectis S.A. | -101.05 Million USD | -430.36% |
| Longeveron Inc. | -21.41 Million USD | -2403.045% |
| Repare Therapeutics Inc. | -93.79 Million USD | -471.428% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -653.105% |
| Revolution Medicines, Inc. | -436.36 Million USD | -22.827% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -8056.704% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -1638.83% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -673.047% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -727.994% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -5363.021% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 114.808% |
| Denali Therapeutics Inc. | -145.22 Million USD | -269.069% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -445604.093% |
| Veru Inc. | -93.15 Million USD | -475.375% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -1882.97% |
| Cingulate Inc. | -23.53 Million USD | -2177.367% |
| Passage Bio, Inc. | -102.06 Million USD | -425.148% |
| Context Therapeutics Inc. | -23.96 Million USD | -2136.573% |
| Exicure, Inc. | -16.91 Million USD | -3068.836% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -183.71% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -1319.28% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -8136.519% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -190.222% |
| Nuvalent, Inc. | -126.21 Million USD | -324.641% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -4996.943% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -516.924% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -1654.77% |
| OmniAb, Inc. | -50.61 Million USD | -958.845% |
| Anew Medical, Inc. | 1.34 Million USD | 39916.287% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -3240.461% |
| Lipocine Inc. | -16.35 Million USD | -3177.729% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -707.267% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -741.739% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -1170.275% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -1017.387% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -2602.723% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 1.018% |
| Ocugen, Inc. | -63.07 Million USD | -749.705% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -459.872% |
| Q32 Bio Inc. | -112.96 Million USD | -374.48% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -3017.595% |
| Alumis Inc. Common Stock | -154.99 Million USD | -245.807% |
| Equillium, Inc. | -13.33 Million USD | -3919.325% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -787.879% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -6609.915% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -2743.194% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -807.175% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -367.992% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -2816.413% |
| Dominari Holdings Inc. | -22.88 Million USD | -2242.352% |
| Edesa Biotech, Inc. | -8.37 Million USD | -6300.172% |
| vTv Therapeutics Inc. | -20.25 Million USD | -2546.8% |
| Bio-Techne Corporation | 168.1 Million USD | 418.835% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | -52.228% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 515.96% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -339.931% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -1312.734% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -375.823% |
| Nkarta, Inc. | -117.5 Million USD | -356.147% |
| BioCardia, Inc. | -11.57 Million USD | -4532.072% |
| Iterum Therapeutics plc | -38.37 Million USD | -1296.828% |